- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Asfotase Alfa
Total 3052 results
-
Stanford UniversityNational Institute on Aging (NIA)Withdrawn
-
University Medical Center GroningenJanssen-Cilag Ltd.; The Interuniversity Cardiology Institute of the NetherlandsCompletedMyocardial InfarctionNetherlands
-
Denali Therapeutics Inc.RecruitingMucopolysaccharidosis IIUnited States, Spain, United Kingdom, Czechia, France, Canada, Italy, Belgium, Netherlands, Germany, Argentina, Sweden, Turkey, Colombia, Brazil
-
National Cancer Institute (NCI)Active, not recruitingOlfactory Neuroblastoma | Esthesioneuroblastoma | Neoplasm of the Nasal CavityUnited States
-
SanofiApproved for marketing
-
AryoGen Pharmed Co.CompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorIran, Islamic Republic of
-
Ari ZimranPfizerActive, not recruitingGaucher Disease, Type 3Israel, Turkey, India
-
ShireCompletedFabry DiseaseCanada, United States
-
ShireCompletedFabry DiseaseUnited States, United Kingdom, Australia, Czechia, Finland, Paraguay, Poland, Slovenia
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageUnited States, Spain, Germany, Sweden, Netherlands, Austria, Belgium, Singapore, Taiwan, Israel, Italy, Denmark, Australia, Thailand, France, Norway, Croatia, Hong Kong, China, Canada, Switzerland, Brazil, Finland
-
Baylor Research InstituteNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II | Glycogenosis 2
-
Xiamen Amoytop Biotech Co., Ltd.Peking University People's HospitalCompletedChronic Hepatitis CChina
-
Zydus Lifesciences LimitedCompletedAnemia | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4India
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Federico II UniversityCompleted
-
Ortho PharmaceuticalsCompleted
-
BiocadCompletedHepatitis | Hepatitis C | Hepatitis C/ Human Immunodeficiency Virus CoinfectionRussian Federation
-
AM-PharmaFGK Clinical Research GmbHRecruiting
-
The University of Hong KongRecruitingMyelofibrosis | Primary Myelofibrosis, Prefibrotic StageHong Kong
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, China, Germany, Italy, Netherlands, Spain, Taiwan, United Kingdom
-
TakedaActive, not recruiting
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, Poland, Germany, France
-
UNICANCERMerck KGaA, Darmstadt, GermanyTerminatedSquamous Cell Carcinoma of Head and NeckFrance
-
Organon and CoCompleted
-
ShireNo longer available
-
Shaare Zedek Medical CenterCompleted
-
LMU KlinikumGenzyme, a Sanofi CompanyCompletedPompe DiseaseGermany, Taiwan, Italy
-
Baylor Research InstituteTexas Scottish Rite Hospital for ChildrenWithdrawnGaucher Disease Type 1 | Gaucher Disease Type 3United States
-
PfizerCompletedHemophilia BCanada, Singapore, Turkey, Croatia, Korea, Republic of, Mexico, Poland, Bulgaria, Malaysia
-
Shin Kong Wu Ho-Su Memorial HospitalUnknown
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Germany, Israel, Italy, Netherlands, Taiwan
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2Netherlands
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease Late-Onset | Glycogen Storage Disease Type II GSD IIUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France
-
Chiesi Farmaceutici S.p.A.Not yet recruiting
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
David L Rogers, MDActive, not recruitingNeuronal Ceroid Lipofuscinosis Type 2United States
-
PfizerCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIChina
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
ShireCompleted
-
ShireQuintiles, Inc.Completed
-
Chiesi Farmaceutici S.p.A.Withdrawn
-
JHL Biotech, Inc.CompletedHealthy SubjectsNetherlands
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States, Israel, France, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, Taiwan, Israel, United Kingdom, France